Sulfonylindoline compounds of formula I,
wherein R1 through R4, Y and Z have defined meanings, a process for preparation of such compounds, and the use as pharmaceutically active substances, particularly for the treatment or inhibition of neurodegeneration, cardiovascular disease, inflammatory disease, hypercholesterolemia, dyslipidemia, obesity or diabetes.
A construct in which at least a part of the magnetic material is coated with a polyhydroxyalkanoate (PHA), and a method for producing a construct by immobilizing a PHA synthesizing enzyme on the surface of the magnetic material, thereby biosynthesizing and coating a PHA.
Structured construct and producing method therefor
申请人:Imamura Takeshi
公开号:US20070003975A1
公开(公告)日:2007-01-04
There is provided a construct in which at least a part of the magnetic material is coated with a polyhydroxyalkanoate (PHA), and a method for producing a construct by immobilizing a PHA synthesizing enzyme on the surface of the magnetic material, thereby biosynthesizing and coating a PHA.
[EN] STRUCTURED CONSTRUCT AND PRODUCING METHOD THEREFOR<br/>[FR] CONSTRUCTION STRUCTUREE, ET PROCEDE DE PRODUCTION A CET EFFET
申请人:CANON KK
公开号:WO2004097417A1
公开(公告)日:2004-11-11
There is provided a construct in which at least a part of the magnetic material is coated with polyhydroxyalkanoate (PHA), and a method for producing a construct by immobilizing a PHA synthesizing enzyme on the surface of the magnetic material thereby biosynthesizing a PHA and coating such PHA on the material.